Vertex Pharmaceuticals Inc
Close on Nov 2, 2026Market cap $140.20BP/E 32.2Yield –
Vertex Pharmaceuticals Development — Salary and employee benefits by Quarter
Development — Salary and employee benefits ($M) ($M)
Vertex Pharmaceuticals Development — Salary and employee benefits: $194M in Q2 2026, up 3.6% from a year earlier.
Where the Q2 2026 figure comes from
“|| Salary and benefits | $ 194.1 | $ 187.3 | 4% | $ 406.7 | $ 383.2 | 6%”
Source: Form 10-Q (vrtx-20260630.htm, filed 2026-08-04) ↗
Reported in Form 10-Q / 10-K MD&A (Development Expenses Disaggregation Table).
Quarterly history
Hover a value to see the sentence it was read from; calculated values show their formula
Cite this data
StockData. (2026). Vertex Pharmaceuticals Development — Salary and employee benefits ($M), quarterly Q1 2017–Q2 2026 [Data set]. Compiled from Vertex Pharmaceuticals SEC filings and investor materials. https://stockdatahq.com/stocks/vrtx/kpis/rd-dev-salary
See every metric in the Vertex Pharmaceuticals KPI table. Data updated Nov 2, 2026.